Case | Treatment | Follow-up (months) | Measurements at last visit | |||||
---|---|---|---|---|---|---|---|---|
Induction | Maintenance | Hb (g/dl) | EOS (%) | Upro (g/24 h) | SCr (mg/dl) | MPO-ANCA (RU/ml) | ||
1 | MP/CTX (6ga) | Aza | 8 | 11.4 | 5 | 0.50 | 1.58 | 320 |
2 | MP/CTX (5.8 g) | Aza | 83 | 13.4 | 6 | 0.10 | 0.56 | 0 |
3 | MP/CTX (6 g) | Aza | 63 | 13.0 | 2 | 2.04 | 1.21 | 0 |
4 | Pred/CTX (6.4 g) | TW | 26 | 13.7 | 2 | 1.02 | 2.46 | 0 |
5 | Pred/MMF | Aza | 28 | 12.1 | 2 | 0.75 | 2.19 | 31.8 |
6 | IA/MP/MMF | Aza | 56 | 11.1 | 3 | 0.14 | 2.26 | 63.3 |
7 | IA/MP/MMF | Aza | 41 | 11.4 | 0 | 1.86 | 2.41 | 21 |
8 | IA/MP/MMF | TW | 46 | 12.8 | 3 | 0.12 | 1.79 | 135 |
9 | MP/MMF | TW | 50 | 13.7 | 1 | 0.2 | 2.30 | 89.9 |
10 | MP/MMF | Pred | 6 | 6.6 | 14 | 0.72 | MHD | 82.5 |
11 | MP/Pred | TW | 47 | 14.0 | 2 | 0.45 | 1.83 | 0 |
12 | MP/Pred | TW | 12 | 12.6 | 0 | 1.83 | 2.40 | 156 |
13 | IA/MP/Pred | Pred | 5 | 10.0 | 1 | 1.38 | MHD | 133.7 |
14b | IA/MP | - | 0 | - | - | - | - | - |